Our guest is Dr. Daniel Parker, an associate professor at the University of Oklahoma Health Sciences Center, who specializes in urologic oncology. He is here to talk with us about Hormone Sensitive Prostate Cancer and treatment intensification. Short on time? Use the below timestamps to jump to any topic section: 0:38 - Introduction 1:02 - What is Hormone Sensitive Prostate Cancer (HSPC)? 2:25 - How common is HSPC? 4:01 - Types of treatment intensification for HSPC 7:16 - What can patients and caregivers expect after treatment for HSPC? 10:46 - Questions for patients and caregivers to ask their doctor 15:35 - Advice for patients and caregivers about treatment for HSPC 17:56 - Final thoughts Supported by an independent educational grant from Astellas and Pfizer, Inc. For more information, please visit www.UrologyHealth.org and don’t forget to subscribe to our free digital magazine, UrologyHealth extra® at www.urologyhealth.org/healthy-living…gyhealth-extra. **** July 6, 2023

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related